The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 267.50
Bid: 260.00
Ask: 275.00
Change: -11.50 (-4.12%)
Spread: 15.00 (5.769%)
Open: 267.50
High: 267.50
Low: 267.50
Prev. Close: 279.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' dealing and Grant of Options

9 Jul 2021 11:46

RNS Number : 7823E
Team17 Group PLC
09 July 2021
 

9 July 2021

 

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Directors' dealing and Grant of Options

 

Team17 Group plc (AIM:TM17) announces that Mark Crawford, Chief Financial Officer, and Martin Hellawell, Senior Non-Executive Director, have made the following purchases of Ordinary Shares:

 

Director

Position

Number of shares acquired

Price per share (p)

Martin Hellawell

Senior Non-Executive Director

10,000

792

Mark Crawford

Chief Financial Officer

4,403

800

 

In addition, in line with the incentivisation strategy set out in the annual report and accounts for the year ending 31 December 2020, the Company has granted options (the "Options") over 176,100 new ordinary shares of £0.01 each in the Company ("Ordinary Shares") under the rules of its Long Term Incentive Plan (the "Plan") to executive directors as follows:

 

Director

Position

Number of options granted

Total options held following this grant

Debbie Bestwick

CEO

150,943

1,123,670

Mark Crawford

Chief Financial Officer

25,157

45,214

 

The Options are granted over Ordinary Shares with no exercise price. The Options are granted subject to the rules of the Plan and based on a stretching range of EPS performance measured over the three years to 31 December 2023. 25% of the award is payable for threshold performance at a CAGR of 10%, with full vesting at a CAGR of 30%.

 

As a result of the above transactions, details of the relevant directors' holdings of Ordinary Shares and options over Ordinary Shares are as follows:

 

Name

No. of Ordinary Shares held

% of issued Ordinary Share capital

No. of Options held

Debbie Bestwick

29,154,162

22.17%

1,123,670

Mark Crawford

11,194

0.01%

45,214

Martin Hellawell

10,000

0.01%

NIL

 

In total, the Company has granted options over 1,382,814 ordinary shares of £0.01 each, representing approximately 1.1 per cent. of the existing issued ordinary share capital.

 

 

 

 

 

1

Details of the person discharging managerial responsibilities

a)

Name

Mark Crawford

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

b)

LEI

2138006EUUCCL4ZI5E51

4

Details of the transaction(s): sections to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each ("Ordinary Shares") and options over Ordinary Shares

 

 

ISIN: GB00BYVX2X20

b)

Nature of the transaction

Acquisition of 4,403 Ordinary Shares and grant of options over 25,157 Ordinary Shares;

c)

Prices(s) and volume(s)

Price(s):

Volume(s)

792p

4,403 Ordinary Shares and 25,157 options

d)

Aggregated information

Not applicable

e)

Date of transaction

8 July 2021

f)

Place of the transaction

London

 

1

Details of the person discharging managerial responsibilities

a)

Name

Debbie Bestwick

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

b)

LEI

2138006EUUCCL4ZI5E51

4

Details of the transaction(s): sections to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of financial instrument, type of instrument

 

Identification code

Options over Ordinary Shares

 

 

ISIN: GB00BYVX2X20

b)

Nature of the transaction

Grant of options over 150,943 Ordinary Shares

c)

Prices(s) and volume(s)

Price(s):

Volume(s)

NIL

150,943

d)

Aggregated information

Not applicable

e)

Date of transaction

8th July 2021

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities

a)

Name

Martin Hellawell

2

Reason for the notification

a)

Position/status

Senior non-executive director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

b)

LEI

2138006EUUCCL4ZI5E51

4

Details of the transaction(s): sections to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of financial instrument, type of instrument

 

Identification code

Ordinary Shares

 

 

ISIN: GB00BYVX2X20

b)

Nature of the transaction

Purchase of 10,000 Ordinary Shares

c)

Prices(s) and volume(s)

Price(s):

Volume(s)

800p

10,000

d)

Aggregated information

Not applicable

e)

Date of transaction

8 July 21

f)

Place of the transaction

London

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Consulting

 

GCA Altium (Nominated Adviser)

Adrian Reed / Paul Lines

 

+44 (0)845 505 4343

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington

team17@vigoconsulting.com

+44 (0)20 7390 0233

 

 

About Team17 Group plc

 

Team17 Group plc is a global provider of games entertainment to a broad audience. It has two main verticals - a games entertainment label and creative partner for indie developers, and a leading developer of educational apps, targeting children under the age of eight.

 

Games label and creative partner

 

Team17 is a games entertainment label and creative partner for independent ("indie") developers, focused on the premium, rather than free to play market, and creating games for the PC, console, mobile and tablet gaming markets.

 

Alongside developing the Company's own games in house ("first party IP"), Team17 also partners with independent developers across the globe to add value to their games in all areas of development and production and in bringing them to market across multiple platforms for fixed percentage royalties ("third party IP").

 

Since foundation in 1990, the Company has launched over 100 games, including the iconic Worms, Overcooked! and Escapists franchises, along with many more including; Yooka-Laylee, Yoku's Island Express, My Time at Portia, Hell Let Loose, Blasphemous, Golf With Your Friends, Neon Abyss and Moving Out making Team17 one of the most prolific developers and diverse partners of games for the indie market.

 

Visit www.team17.com for more info.

EU Market Abuse Regulation

 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKLFBFDLZBBX
Date   Source Headline
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.